The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but ...

The new study, spearheaded by experts at UCL and the universities of Cambridge and Edinburgh, with support from the BHF Data ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

Children, young people were more likely to experience heart, vascular or inflammatory problems after a COVID-19 infection ...

Pfizer and Novo Nordisk's fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted ...

Pfizer also has set its sights on becoming a giant in oncology, and to support this, completed the acquisition of Seagen in 2023. Two of Seagen's products in the most recent quarter delivered ...

Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales growth that’s driving its battle for the obesity startup Metsera.

Pfizer raised its full-year profit forecast for the second consecutive quarter and reported a higher-than-expected ...